Variables | Indication for treatment of patients | |||||||
Deep vein thrombosis | Embolie pulmonary | Mechanical valve prosthesis | Complete atrial fibrillation arrhythmia | Spontaneous Intracardiac contrast | CPC* in primary PAH | RM*** percutaneous route complicated by ACFA | % | |
Duration |
|
|
|
|
|
|
|
|
<6 mouths | - | 2 | - | 3 | - | - | - | 12.5 |
6 months to 2 years | 4 | 2 | 2 | 8 | 1 | 1 | 1 | 47.5 |
2 à 5 years | 5 | 2 | 2 | 4 | 1 | - | - | 35.0 |
5 à 10 years | 1 | 1 |
| - | - | - | - | 5.0 |
Type of treatment |
|
|
|
|
|
|
|
|
Fluindione | 9 | 7 | 3 | 11 | 1 | - | - | 77.5 |
Acenocoumarol | 1 | - | 1 | 4 | - | 1 | 1 | 20.0 |
Warfarin | - | - | - | - | - | - | 1 | 2.5 |
% | 25.00 | 17.50 | 10.00 | 37.50 | 5.00 | 2.50 | 2.50 | 100 |